Indonesian court has found several drug manufacturers at fault for producing and distributing toxic cough syrup. The court ruled that these firms were responsible for a number of illnesses and deaths related to the consumption of this product, many of which were among children. The exact legal and financial implications of this ruling are still to be determined. The drug manufacturers may likely appeal the verdict, so the full impact of this ruling may not immediately be clear. The case has drawn global attention to the issue of drug safety regulations in developing countries.